|
Market Cap (24-Jun) $7,649,007 (1,598th) |
Close (30-Jun) $0.024 |
Volume (30-Jun) 2,170,184 |
Shortsold (2-Feb) 3,141 (0.00%) (662nd) |
|
52w High $0.008 |
52w Low $0.002 |
P/E - |
EPS 0 |
1AD released this announcement to the ASX on 3 June 2021, 15:42. The announcement is not marked as price sensitive, and is 44 page(s) in length and 10.83MB in size.
You can view all announcements from 1AD and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from 1AD | |
|---|---|
| AD-214 clinical trial approval | 29 June 2023, 8:21 |
| Change in substantial holding | 31 May 2023, 13:30 |
| Change in substantial holding | 31 May 2023, 9:34 |
| AdAlta corporate presentation, upcoming events | 3 June 2021, 15:42 |
| GE Healthcare collaboration advances to next stage | 24 May 2021, 8:44 |
| AdAlta granted Japanese patent for AD-214 | 19 May 2021, 9:15 |
| CSO presentation at ILD Drug Development Summit | 28 April 2021, 17:24 |
You must be logged in to post a reply.
AdAlta 